AC
BIO icon

Armistice Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Armistice Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,827
Closed -$932K – 212
2025
Q1 		$932K Buy
+3,827
New +$1.15M 0.02% 168
2021
Q3 		– Sell
-18,000
Closed -$11.6M – 140
2021
Q2 		$11.6M Sell
18,000
-20,000
-53% -$12.2M 0.3% 85
2021
Q1 		$21.7M Buy
38,000
+5,000
+15% +$2.96M 0.7% 52
2020
Q4 		$19.2M Buy
33,000
+13,000
+65% +$7.4M 0.86% 46
2020
Q3 		$10.3M Buy
+20,000
New +$10.1M 0.48% 64
2020
Q1 		– Sell
-20,000
Closed -$7.4M – 83
2019
Q4 		$7.4M Buy
+20,000
New +$7.05M 0.59% 58

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.13B AUM 21.51% 1-Year Est. Return